J. Maa

Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients

C. Cohen, J. Maa, R. Campo, 2010, International journal of STD & AIDS.

Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)

K. Mounzer, R. Ebrahimi, E. Dejesus, 2008 .

Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients

R. Ebrahimi, E. Dejesus, B. Young, 2008 .